Lebwohl M, Kircik L, Moore A, Stein Gold L, Del Rosso J, Draelos Z, Gooderham M, Green L, Herbert A, Papp K, Bagel J, Bhatia N, Ferris L, Jones T, Kempers S, Pariser D, Yamauchi P, Zirwas M, Feng A, Burnett P, Higham R, Berk D. Once-Daily Roflumilast Cream 0.3%, a Potent Phosphodiesterase-4 Inhibitor, Provided Safe and Effective Treatment of Psoriasis in the DERMIS-1 and DERMIS-2 Phase 3 Trials. J of Skin [Internet]. 2021 Nov. 5 [cited 2024 Jul. 1];5(6):s42. Available from: https://jofskin.org/33014/index.php/skin/article/view/1393